Market Update: Regeneron, UPS, and Zebra
Regeneron (REGN) has seemingly overcome its bear phase, with shares rising by around 12% to over $650 on Tuesday.
The company reported a 0.8% increase in revenue to $3.75 billion, driven by strong sales of Dupixent, which reached $4.9 billion. This offset weak sales from EYLEA, although EYLEA HD sales grew by 42% to $663 million.
Regeneron also lowered its R&D and SG&A expense forecast for the fiscal year to manage costs.
UPS and Zebra Updates
UPS, despite being down nearly 25% in 2025, added 8.0% after posting non-GAAP EPS of $1.74 on revenue of $21.4 billion (-3.6% Y/Y). The company announced a massive 48,000 job cut, with 34,000 cuts in the operational unit and 14,000 at the management level.
Zebra (ZBRA) continued its downtrend, which began in August and accelerated in October, with the stock losing 11%.
No specific quotes available in the text.
Author's summary: Regeneron and UPS show positive signs amidst market fluctuations.
- Regeneron (REGN): shares rose by around 12% to over $650
- UPS: added 8.0% after posting results, announced 48,000 job cuts
- Zebra (ZBRA): continued downtrend, stock lost 11%